Results 251 to 260 of about 74,680 (298)
Some of the next articles are maybe not open access.

Polypharmacy and incontinence

Zeitschrift für Gerontologie und Geriatrie, 2012
Polypharmacy as well as urinary incontinence are common geriatric problems. Possible adverse drug effects remain a matter of concern in geriatric medicine and must be considered in urinary incontinence. The occurrence or aggravation of lower urinary tract symptoms might be caused by medication, especially when the symptom is newly diagnosed.
H, Talasz, M, Lechleitner
openaire   +2 more sources

Polypharmacy in Oncology

Clinics in Geriatric Medicine, 2022
Polypharmacy, defined as taking five medications or more, is a common geriatric syndrome. It is especially prevalent in older adults with cancer. For older patients with breast, lung, prostate, and colorectal cancer and chronic lymphocytic leukemia, polypharmacy has numerous adverse effects, including interactions with medications prescribed for other ...
Justin J, Cheng   +4 more
openaire   +2 more sources

Antipsychotic Polypharmacy

Current Pharmaceutical Design, 2004
The administration of more than one drug for a single medical condition is considered to be polypharmacy. There are many possible reasons for polypharmacy: (1) psychosis is a chronic disease that cannot be cured; (2) expectations to improve patients' quality of life beyond what drugs can actually do is high; (3) the lack of side effects and ...
J, Ananth   +2 more
openaire   +2 more sources

Comorbidities and Polypharmacy

Heart Failure Clinics, 2014
Heart failure (HF) is predominantly a disease that affects the elderly population, a cohort in which comorbidities are common. The majority of comorbidities and the degree of their severity have prognostic implications in HF. Polypharmacy in HF is common, has increased throughout the past 2 decades, and may pose a risk for adverse drug interactions ...
Thomas G, von Lueder, Dan, Atar
openaire   +2 more sources

Problems of polypharmacy

BMJ, 2013
The King’s Fund report discussed by Wise covers much ground, but its focus is blurred and it misses some core points.1 2 It would take years to implement the sensible changes proposed in managing multimorbidity and in prescribing in care homes. But what do the authors think should be done now? They strangely omit the role of the patient. Patients (and
Andrew, Herxheimer, Patricia, McGettigan
openaire   +2 more sources

Polypharmacy in schizophrenia

International Journal of Psychiatry in Clinical Practice, 2006
In contrast to research studies that limit the use of concomitant psychotropic medications in the treatment of schizophrenia, polypharmacy is common in real-world, clinical practice. The use of psychotropic medications as an adjunct to antipsychotic agents is often necessitated by the poor response to monotherapy with one antipsychotic agent.
Prakash S, Masand   +2 more
openaire   +2 more sources

Polypharmacy and the Elderly

Journal of Infusion Nursing, 2003
Polypharmacy is the concurrent use of several different medications used by the same individual, which in some cases can lead to drug-drug interactions. Elderly patients often are faced with polypharmacy when they have multiple disease processes. Declining organ function, as part of the normal aging process, adds to the problem of adverse drug effects ...
openaire   +2 more sources

Polypharmacy and malnutrition

Current Opinion in Clinical Nutrition and Metabolic Care, 2013
Malnutrition and polypharmacy increase with age and polymorbidity and their relationship is based on a number of mechanisms. The occurrence of malnutrition in both in-patients and out-patients and its dependence on polymorbidity and age are well known, but the interrelation of polypharmacy and malnutrition has been far less investigated.
Zdenek, Zadak   +3 more
openaire   +2 more sources

Osteoporosis and polypharmacy

Zeitschrift für Gerontologie und Geriatrie, 2012
Osteoporosis is very common in elderly patients. Despite the severe health-related consequences for individual patients and the socioeconomic costs caused by osteoporotic fractures, treatment rates are still low. Due to drug interactions and patient compliance, polypharmacy is often mentioned as a reason for undertreatment.
M, Gosch   +3 more
openaire   +2 more sources

Polypharmacy in Elders

American Journal of Nursing, 1996
gency department at 7 PM on the advice of her physician after she complained of chest pain and difficulty breathing. The physician called ahead to notify the ED and to request a cardiology consult. Six months ago, Ms. Bethel had an MI and underwent coronary angioplasty with insertion of a stent. At the ED, she characterized her epigastric pain as worse
L L, Lilley, R, Guanci
openaire   +2 more sources

Home - About - Disclaimer - Privacy